Wallkill BioPharma Inc.

Biotechnology company · Wilmington, Delaware, United States

Wallkill BioPharma Inc. is a biotechnology company headquartered in Wilmington, Delaware, United States. Its earliest recorded incorporation is in 2017. It has reported private securities offerings to the US SEC, most recently $207,513 sold in a notice filed in 2018.

Profile compiled from public records. Is this your company? Request a correction or update

Wallkill BioPharma at a glance

Typebiotechnology company

HeadquartersWilmington, Delaware, United States

Earliest incorporation on record2017

SEC CIK1735845

What does Wallkill BioPharma do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $207,513 sold (2018).

Frequently asked questions about Wallkill BioPharma

Where is Wallkill BioPharma headquartered?

Wallkill BioPharma Inc. is headquartered in Wilmington, Delaware, United States.

What does Wallkill BioPharma do?

Wallkill BioPharma Inc. is a biotechnology company.

When was Wallkill BioPharma founded?

The earliest incorporation on record for Wallkill BioPharma Inc. is in 2017, according to public company registers.

Similar companies

Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
OpiAID, LLCWilmington, North Carolina, United States
Synnovation Therapeutics, Inc.Wilmington, Delaware, United States
Treadwell CorporationWilmington, North Carolina, United States
NiKang Therapeutics, Inc.Wilmington, Delaware, United States
GPN Vaccines, Inc.Wilmington, Delaware, United States
Advanced Materials Technology, Inc.Wilmington, Delaware, United States
Compact Membrane Systems, Inc.Wilmington, Delaware, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences